[4P] Movement Disorders

[4P-334] The novel nucleic acid analog, COA-Cl exerted the neuroprotective effect in acute phase after spinal cord injury.

〇Naoyuki Himi¹, Issei Sakamoto^1,2, Emi Nakamura-Maruyama¹, Ikuko Tsukamoto³, Osamu Miyamoto¹ (1.Dept Physiol 2, Kawasaki Med Sch, Kurashiki, Japan, 2.Dept Orthop Surg, Kawasaki Med Sch, Kurashiki, Japan, 3.Dept Pharmaco-bio-informatics, Kagawa Univ, Miki, Japan)

Keywords:COA-Cl, Spinal cord injury, Neuroprotection